| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00151736 Details | 2012-06-11 Interventional | 2 | 88 | Chlorambucil Etodolac Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | - - | |||
| NCT00910299 Details | 2012-06-08 Interventional | 2 | 423 | Clopidogrel Prasugrel Hydro… Coronary Artery… Coronary Artery… | Due to the low rate of primary endpoint events experienced in the study to date The study was terminated early, and no formal statistical time-to-event analysis was performed. | |||
| NCT00638833 Details | 2012-06-08 Interventional | 2 | 20 | Memantine Multiple Sclero… Sclerosis | Unexpected side-effects: reversible and mild to moderate neurological impairment - | |||
| NCT01070745 Details | 2012-06-07 Interventional | 2 | 0 | Ibuprofen Indomethacin Ductus Arterios… Patent Ductus A… | Changes in approach to PDA therapy - | |||
| NCT00618384 Details | 2012-06-07 Interventional | 2 | 43 | Sorafenib Carcinoma Carcinoma, Hepa… Hepatocellular … | - - | |||
| NCT00383214 2005-000706-31 Details | 2012-06-07 Interventional | 3 | 54 | Epratuzumab Lupus Erythemat… Systemic Lupus … | - - | |||
| NCT00148252 Details | 2012-06-07 Interventional | 4 | - | Mycophenolic Ac… Renal Transplan… | To high rejection rate in CsA withdrawal arm - | |||
| NCT00050297 Details | 2012-06-07 Interventional | 2 | - | N-(6-methoxy-5-… Prostatic Neopl… Prostate Cancer | - - | |||
| NCT00048659 Details | 2012-06-07 Interventional | 2 | - | N-(6-methoxy-5-… Prostatic Neopl… Hormone-Refract… | - - | |||
| NCT00586794 Details | 2012-06-06 Interventional | 3 | 24 | Sildenafil Citr… Eisenmenger Com… Familial Primar… Hypertension Pulmonary Arter… Pulmonary Arter… | - - | |||
| NCT00564993 2007-003461-41 Details | 2012-06-06 Interventional | 3 | 53 | Dobutamine Tetralogy of Fa… | - - | |||
| NCT00536003 Details | 2012-06-06 Interventional | 3 | 384 | Progesterone Obstetric Labor… Perinatal Death Premature Birth Morbidity Perinatal Morta… Preterm Deliver… | - - | |||
| NCT00005608 Details | 2012-06-06 Interventional | 2 | - | Calcium Leucovorin Levoleucovorin Tegafur Breast Neoplasm… Breast Cancer | Drug was pulled from the market. - | |||
| NCT00224679 Details | 2012-06-05 Interventional | 3 | - | Aspirin Adenoma Recurrence Colon Adenomas | - - | |||
| NCT00126789 Details | 2012-06-05 Interventional | 3 | 24 | Fentanyl Cancer Pain Cancer Pain | Based on PK data, product did not meet requirement for further development. - | |||
| NCT00126763 Details | 2012-06-05 Interventional | 3 | 105 | Fentanyl Chronic Pain Pain | PK results suggested product did not meet requirement for further development. - | |||
| NCT00437164 Details | 2012-06-04 Interventional | 2 | 1 | Insulin Insulin, Globin… Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | Company decision not related to safety. - | |||
| NCT00403182 2005-000986-20 Details | 2012-06-01 Interventional | 3 | 0 | Letrozole Breast Neoplasm… Breast Cancer | study halted prematurely, prior to enrollment of first participant - | |||
| NCT01491139 2010-023599-24 Details | 2012-05-30 Interventional | 1 | 0 | Olaparib Carcinoma Carcinoma, Squa… Squamous Cell C… | Study stopped due to issues surrounding development and formulation of olaparib - | |||
| NCT00705770 Details | 2012-05-30 Interventional | 2/3 | 0 | Anecortave Hydrocortisone Glaucoma Glaucoma, Open-… Open-Angle Glau… | Change in study design - |